THE 2026 Asian Conference on Pharmacoepidemiology (ACPE) will be held in Melbourne this year, hosted by the Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences.
Taking place from 30 Oct to 01 Nov at Monash Parkville Campus, the event will welcome more than 300 researchers, global leaders, clinicians and policymakers from across the Asia-Pacific.
Featuring educational sessions and keynote lectures, "the event will boost global collaboration in pharmacoepidemiology and related disciplines including pharmacovigilance, health economics and data sciences", according to a statement from Monash University.
CMUS Director, Professor Simon Bell, noted the importance of hosting the event in the city for the first time, which will "build research capacity in pharmacoepidemiology".
"The importance of rigorous pharmacoepidemiological studies investigating post-marketing safety and effectiveness is rapidly gaining recognition," Bell said.
"Our conference will have a special focus on providing opportunities for early to mid-career researchers."
Associate Professor Jenni Ilomaki from CMUS will be conference chair and is looking forward to sharing the advances in electronic health data in APAC, which are "transforming medication safety and effectiveness research". JHM
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Mar 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Mar 26
